Gujarat: 3 companies restrained from launching diabetes medicine

Latest Posts

Brazil coronavirus deaths climb to 46,510, cases near 1 million

By Admin

Brazil recorded 1,269 additional COVID-19 deaths on Wednesday, bringing its official death toll from the novel coronavirus to 46,510, the most in the world outside...

Comments closed

Requiring masks ‘political hazard’ as COVID-19 surges in California breadbasket

By Admin

The first wave of COVID-19 came slowly to San Joaquin County in the heart of California's breadbasket, but the much-feared second surge is roaring through,...

Comments closed

Mothers as ‘trauma surgeons:’ the anguish of raising black boys in America

By Admin

Raising black boys in America involves "constant mental anguish," Danielle Pattillo, a special education teacher in New York City and mother to two sons, ages...

Comments closed

Record spike in new coronavirus cases reported in six U.S. states as reopening accelerates

By Admin

New coronavirus infections hit record highs in six U.S. states on Tuesday, marking a rising tide of cases for a second consecutive week as most...

Comments closed

Some Amazon villagers eschew drugs for COVID-19, take ‘toothache plant’ herbal tea

By Admin

Some villagers in the eastern Amazon are spurning Brazilian government advice to take the malaria drug hydroxychloroquine to keep the novel coronavirus at bay and...

Comments closed

A commercial court here has temporarily restrained three Gujarat-based pharmaceutical companies – Cadila Healthcare Ltd, Maan Pharmaceutical Ltd and West Coast Pharmaceutical Works Ltd – from manufacturing and launching in the market a medicine for Type-2 diabetes.

Original source: https://health.economictimes.indiatimes.com/news/pharma/gujarat-3-companies-restrained-from-launching-diabetes-medicine/68980349?utm_source=RSS&utm_medium=ETRSS

Also Read: JB Chemicals gets USFDA nod for generic product